Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Alzheimers Dement. 2009 Jul;5(4):318–323. doi: 10.1016/j.jalz.2009.04.1230

Table 2.

CRP group and cognitive outcomes

CRP Groups
Variable Undetectable < 0.5 mg/dL Detectable 0.5 – 0.7 mg/dL Elevated ≥0.8 mg/dL p-value
MMSE score (mean ± SD) 25.1 ± 4.9 24.0 ± 5.2 22.5 ± 7.5 0.01*
Distribution of MMSE scores, N (%)
 Score 28 – 30 35 (38) 28 (23) 28 (30) 0.09
 Score 25 – 27 27 (30) 43 (36) 23 (24)
 Score 14 – 24 25 (27) 41 (35) 30 (32)
 Score < 13 4 (4) 7 (6) 11 (12)
 Missing data 1 (1) 0 (0) 2 (2)
Distribution of CDR scores, N (%)
 Score = 0 50 (54) 56 (47) 39 (42) 0.02*
 Score = 0.5 34 (38) 40 (34) 30 (33)
 Score = 1 2 (2) 13 (11) 6 (6)
 Score = 2 4 (4) 6 (5) 9 (10)
 Score = 3 1 (1) 3 (2) 8 (9)
 Missing data 1 (1) 1 (1) 2 (2)
Frequency of cognitive diagnosis, N (%)
 Nondemented 44 (48) 50 (42) 36 (38) 0.004*
 CIND 38 (41) 39 (33) 25 (27)
 Demented 10 (11) 30 (25) 33 (35)
Dementia etiology, N (%)
 AD 9 (90) 21 (70) 22 (67) 0.41
 VD or AD + VD 0 (0) 8 (27) 9 (27)
 Other 1 (10) 1 (3) 2 (6)
*

p < 0.05

not included in Chi-square analysis

CRP = C-reactive protein; SD = standard deviation; MMSE = Mini-Mental Status Exam; CDR = Clinical Dementia Rating; CIND = Cognitive Impairment Not Demented; AD = Alzheimer’s Disease; VD = Vascular Dementia